CAVEAT Trial Hints at New AML Path for Fit Seniors | Blood Cancers Today
Results from the phase 1b study suggest venetoclax plus modified chemotherapy is an effective and well-tolerated approach.
Results from the phase 1b study suggest venetoclax plus modified chemotherapy is an effective and well-tolerated approach.
Good fitness can reduce the risk of dementia and promote healthy brain aging. This recognition should be included in updated health recommendations, say researchers behind…
Bryan Johnson, a tech mogul, underwent a full-body plasma replacement. He aims to reverse aging. He replaced his plasma with albumin. This is part of
“Eddington,” while not a comedy, presents an angry, sinister, and maybe crazy new America that it views with a deadpan tone of trepidatious glee. And…
This case-control of older US adults examines risk of Parkinson Disease by proximity of residence to a golf course.
Read our coverage of the major medical conferences that impact thoracic oncologists and surgeons.
The last 2 decades have seen a paradigm shift in the treatment landscape of metastatic gastric and gastroesophageal adenocarcinomas, with most of the progress occurring…
Sankalp Arora, MBBS, a second-year fellow at MD Anderson, presented data on FLT3 inhibitors in FLT3-TKD-mutated AML at the HemOnc Pulse Live.
Immunotherapy for Urothelial Cancer: Types, Success Rate, Side Effects and More
This JAMA Internal Medicine Patient Page describes the process of slowly and carefully cutting down on unnecessary medications with the guidance of a health care…
A study examined one medical center’s adherence to gout management guidelines regarding the use of urate-lowering therapy (ULT) to lower uric acid (UA) levels.